Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_assertion description "[This article reviews the MDR related genes, major-vault protein (MVP), anti-apoptotic protein (Bcl-2) and the molecular mechanisms that may contribute to chemoresistance, in addition to the upregulated MDR phenotypes present in CSCs that has recently been identified in gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_assertion evidence source_evidence_literature NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_assertion SIO_000772 18259841 NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_assertion wasDerivedFrom befree-2016 NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_assertion wasGeneratedBy ECO_0000203 NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.
- befree-2016 importedOn "2016-02-19" NP654415.RA6XGcQHySpWyLOgTEEF3IxlH380xrFp7IuV3Qa9-mGSY130_provenance.